Moderna has begun vaccinating participants in a Phase 1 clinical trial of mRNA 1469, an investigational vaccine candidate designed to protect against Bundibugyo ebolavirus, or BDBV, a strain of Ebola virus disease for which no approved vaccine currently exists. …
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News -
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech